Schostak, Martin

A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ). [electronic resource] - Urologia internationalis 2020 - 263-268 p. digital

Publication Type: Clinical Trial, Phase IV; Journal Article

1423-0399

10.1159/000503870 doi


Aged
Antineoplastic Agents--adverse effects
Carcinoma, Renal Cell--drug therapy
Everolimus--adverse effects
Female
Humans
Indazoles
Kidney Neoplasms--drug therapy
Male
Middle Aged
Prospective Studies
Pyrimidines--therapeutic use
Sulfonamides--therapeutic use
Sunitinib--therapeutic use
Treatment Failure
Treatment Outcome